Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related deaths, with a low overall survival rate. Anaemia is one of the most common cancer side effects, reducing the patient’s survival time among other things. Lung cancer patients have the highest incidence of anaemia, with 50–70% of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadowska, Katarzyna, Błasiak, Piotr, Rzechonek, Adam, Bil-Lula, Iwona, Śliwińska-Mossoń, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818260/
https://www.ncbi.nlm.nih.gov/pubmed/36612220
http://dx.doi.org/10.3390/cancers15010224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818260/
https://www.ncbi.nlm.nih.gov/pubmed/36612220
http://dx.doi.org/10.3390/cancers15010224

Ejemplares similares